Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?

Sean Mahase, Himanshu Nagar

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Hypofractionated radiotherapy in the adjuvant or salvage setting is not a standard option for prostate cancer radiotherapy outside of an investigational trial. Prospective trials are currently ongoing to address efficacy and safety concerns. While smaller studies show conflicting data regarding toxicity, initial evidence from larger clinical trials appears to demonstrate that hypofractionated postoperative radiotherapy is as effective and safe as conventionally fractionated courses.

Original languageEnglish (US)
Pages (from-to)9-16
Number of pages8
JournalEuropean Urology Open Science
Volume22
DOIs
StatePublished - Dec 2020

All Science Journal Classification (ASJC) codes

  • Urology

Fingerprint

Dive into the research topics of 'Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?'. Together they form a unique fingerprint.

Cite this